These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3723987)

  • 1. [Initial experiences in the treatment of children with metastatic and recurrent neuroblastoma using meta-iodobenzylguanidine].
    Klingebiel T; Feine U; Niethammer D; Müller-Schauenburg W; Schwabe D; Maul FD; Gerein V; Fischer M; Gahr M; Kraz K
    Klin Padiatr; 1986; 198(3):230-6. PubMed ID: 3723987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [131(I)-meta-iodobenzylguanidine treatment of 32 children with therapy-refractory neuroblastoma].
    Berthold F; Feine U; Fischer M; Gerein V; Klingebiel T; Maul FD; Waters W; Wehinger H; Treuner J
    Klin Padiatr; 1988; 200(3):226-9. PubMed ID: 3062260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of neuroblastoma with [131I]metaiodobenzylguanidine: long-term results in 25 patients.
    Klingebiel T; Feine U; Treuner J; Reuland P; Handgretinger R; Niethammer D
    J Nucl Biol Med (1991); 1991; 35(4):216-9. PubMed ID: 1823821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with meta-[131I]iodobenzylguanidine and cisplatin in stage IV neuroblastoma.
    Mastrangelo S; Tornesello A; Diociaiuti L; Riccardi R; Rufini V; Troncone L
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):69-71. PubMed ID: 9002754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of neuroblastoma with [131I]MIBG at diagnosis.
    Troncone L; Rufini V; Luzi S; Mastrangelo R; Riccardi R
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):65-8. PubMed ID: 9002753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Place of meta-[131I]iodobenzylguanidine in the treatment of neuroblastoma: the Genoa experience.
    Garaventa A; Pianca C; Conte M; Nigro M; De Bernardi B; Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Villavecchia GP
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):58-60. PubMed ID: 9002751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment with [131I] metaiodobenzylguanidine and surgical resection of advanced neuroblastoma.
    van Hasselt EJ; Heij HA; de Kraker J; Vos A; Voûte PA
    Eur J Pediatr Surg; 1996 Jun; 6(3):155-8. PubMed ID: 8817208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of [131I]metaiodobenzylguanidine therapy of neuroblastoma: seven years after.
    Hör G; Maul FD; Kornhuber B; Schwabe D; Hesse J; Manegold KH; Baüm RP; Gerein V
    J Nucl Biol Med (1991); 1991; 35(4):207-15. PubMed ID: 1823820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MIBG-treatment in neuroblastoma; experiences of the Tübingen/Frankfurt group.
    Treuner J; Gerein V; Klingebiel T; Schwabe D; Feine U; Happ J; Niethammer D; Maul F; Dopfer R; Kornhuber B
    Prog Clin Biol Res; 1988; 271():669-78. PubMed ID: 3406023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experiences in the treatment of neuroblastoma with 131I-metaiodobenzylguanidine.
    Treuner J; Klingebiel T; Feine U; Buck J; Bruchelt G; Dopfer R; Girgert R; Müller-Schauenburg W; Meinke J; Kaiser W
    Pediatr Hematol Oncol; 1986; 3(3):205-16. PubMed ID: 2484676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative [131I]metaiodobenzylguanidine therapy of neuroblastoma at diagnosis ("MIBG de novo").
    Hoefnagel CA; de Kraker J; Voûte PA; Valdés Olmos RA
    J Nucl Biol Med (1991); 1991; 35(4):248-51. PubMed ID: 1823828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of [131I]metaiodobenzylguanidine therapy for patients with refractory neuroblastoma.
    Matthay KK; Huberty JP; Hattner RS; Ablin AR; Engelstad BL; Zoger S; Hasegawa BH; Price D
    J Nucl Biol Med (1991); 1991; 35(4):244-7. PubMed ID: 1823827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [131I]metaiodobenzylguanidine and high-dose chemotherapy with bone marrow rescue in advanced neuroblastoma.
    Corbett R; Pinkerton R; Tait D; Meller S
    J Nucl Biol Med (1991); 1991; 35(4):228-31. PubMed ID: 1823824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [131I]MIBG as a first line treatment in advanced neuroblastoma.
    Hoefnagel CA; De Kraker J; Valdés Olmos RA; Voûte PA
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):61-4. PubMed ID: 9002752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [131I]metaiodobenzylguanidine therapy after conventional therapy for neuroblastoma.
    Hoefnagel CA; Voûte PA; De Kraker J; Valdés Olmos RA
    J Nucl Biol Med (1991); 1991; 35(4):202-6. PubMed ID: 1823819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic use of [131I]metaiodobenzylguanidine in neuroblastoma: a phase II study in 26 patients. "Société Française d'Oncologie Pédiatrique" and Nuclear Medicine Co-investigators.
    Lumbroso J; Hartmann O; Schlumberger M
    J Nucl Biol Med (1991); 1991; 35(4):220-3. PubMed ID: 1823822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of [131I]metaiodobenzylguanidine in the treatment of neuroblastoma after conventional therapy.
    Troncone L; Rufini V; Riccardi R; Lasorella A; Mastrangelo R
    J Nucl Biol Med (1991); 1991; 35(4):232-6. PubMed ID: 1823825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a benefit of 131 I-MIBG therapy in the treatment of children with stage 4 neuroblastoma? A retrospective evaluation of The German Neuroblastoma Trial NB97 and implications for The German Neuroblastoma Trial NB2004.
    Schmidt M; Simon T; Hero B; Eschner W; Dietlein M; Sudbrock F; Bongartz R; Berthold F; Schicha H
    Nuklearmedizin; 2006; 45(4):145-51; quiz N39-40. PubMed ID: 16964339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [131I]metaiodobenzylguanidine therapy in advanced neuroblastoma.
    Claudiani F; Garaventa A; Bertolazzi L; Villavecchia GP; Cabria M; Scopinaro G; Bestagno M; Guerra P; Canevarollo N; Scielzo G
    J Nucl Biol Med (1991); 1991; 35(4):224-7. PubMed ID: 1823823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma.
    Matthay KK; Yanik G; Messina J; Quach A; Huberty J; Cheng SC; Veatch J; Goldsby R; Brophy P; Kersun LS; Hawkins RA; Maris JM
    J Clin Oncol; 2007 Mar; 25(9):1054-60. PubMed ID: 17369569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.